Drug Shortage Report for KENALOG-40 INJECTION
Report ID | 166071 |
Drug Identification Number | 01999869 |
Brand name | KENALOG-40 INJECTION 40MG/ML |
Common or Proper name | Triamcinolone Acetonide |
Company Name | BRISTOL-MYERS SQUIBB CANADA |
Market Status | MARKETED |
Active Ingredient(s) | TRIAMCINOLONE ACETONIDE |
Strength(s) | 40MG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR INTRA-ARTICULAR INTRAMUSCULAR INTRA-ARTICULAR |
Packaging size | 5mL |
ATC code | H02AB |
ATC description | CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2022-08-04 |
Actual start date | 2022-08-04 |
Estimated end date | 2023-01-27 |
Actual end date | 2023-01-30 |
Shortage status | Resolved |
Updated date | 2023-01-31 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v9 | 2023-01-31 | English | Compare |
v8 | 2023-01-27 | French | Compare |
v7 | 2023-01-27 | English | Compare |
v6 | 2023-01-27 | English | Compare |
v5 | 2023-01-27 | English | Compare |
v4 | 2022-08-05 | English | Compare |
v3 | 2022-08-04 | French | Compare |
v2 | 2022-08-04 | English | Compare |
v1 | 2022-08-04 | English | Compare |
Showing 1 to 9 of 9